Normal pregnancy outcome after inadvertent exposure to long-acting gonadotrophin-releasing hormone agonist in early pregnancy

Human Reproduction

Volumn 14, Issue 5, 1999, Pages 1368-1371

  Taskin, O ^a,b   Gokdeniz, R ^a   Atmaca, R ^a   Burak, F ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Zafer Mahallesi   (Turkey)

Author keywords

GnRHa; Luteolysis; Pregnancy; Teratogenicity

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; TRIPTORELIN;

ADULT; AMENORRHEA; AMNIOCENTESIS; ARTICLE; CLINICAL ARTICLE; CONTRACEPTION; EMBRYOTOXICITY; ENDOMETRIOSIS; FEMALE; FETUS ECHOGRAPHY; HUMAN; KARYOTYPE; LAPAROSCOPY; PREGNANCY; PRENATAL EXPOSURE;

EID: 0032946190     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.5.1368     Document Type: Article

References (27)

1. Abu-heija, A.T., Fleming, R., Yates, R.W. and Coutts, J.R. (1995) Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy: comparisons in patients with normal or elevated luteinizing hormone. Hum. Reprod., 10, 3317-3319.
2. Balasch, J., Martinez, F., Jove, I. et al. (1993) Inadvertent gonadotropin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum. Reprod., 8, 1148-1151.
3. Cahill, D.J., Fountain, S.A., Fox, R. et al. (1994) Outcome of inadvertent administration of gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy. Hum. Reprod., 7, 1243-1246.
4. Chetkowski, R.J., Kruse, L.R. and Nass, T.E. (1989) Improved pregnancy outcome with addition of leuprolide acetate to gonadotrophins for in vitro fertilization. Fertil. Steril., 52, 250-255.
5. Dicker, D., Goldman, J.A., Vagman, I. et al. (1989) Pregnancy outcome following early exposure to maternal luteinizing-hormone-releasing hormone agonist (buserelin). Hum. Reprod., 4, 250-251.
6. Elefant, E., Biour, B., Blumberg-Tick, J. et al. (1995) Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptorelin. Fertil. Steril., 63, 111-113.
7. Eley, R.M. (1987) The effect of LHRH analogs on pregnancy in the baboon. Contraception, 35, 389-393.
8. Ferner, A.J., Berkeley, A.S. and Cholst, I.N. (1988) Pretreatment with a subcutaneous gonadotropin-releasing hormone agonist in an in vitro fertilization cycle resulting in a viable pregnancy. J. In Vitro Fertil. Embryo Transf., 54, 234-236.
9. Forman, R., Robinson, J., Egan, D. et al. (1990) Ectopic pregnancy after luteal phase initiation of gonadotrophin-releasing hormone analog before in-vitro fertilization. Fertil. Steril., 54, 169-170.
10. Ghazi, D.M., Kemmann, E. and Hammond, J.M. (1991) Normal pregnancy outcome after early maternal exposure to gonadotropin releasing hormone agonist. A case report. J. Reprod. Med., 36, 173-174.
11. Golan, A., Ron-El, R., Herman, A. et al. (1990) Fetal outcome following inadvertent administration of long-acting DTRP6 GnRH microcapsules during pregnancy: a case report. Hum. Reprod., 5, 123-124.
12. Har-Toov, J., Brenner, S.H., Jaffa, A. et al. (1993) Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical pseudomenopause. Fertil. Steril., 59, 446-447.
13. Herman, A., Ron-El, R., Golan, A. et al. (1992) Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long acting agonist of gonadotrophin-releasing hormone. Hum. Reprod., 7, 465-468.
14. Hughes, E.G, Sagle, M.A., Federkow, D.M. et al. (1992) The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomised controlled trials. Fertil. Steril., 58, 888-896.
15. Isherwood, P.J., Ibrahim, Z.H.Z., Matson, P.L. et al. (1990) Endocrine changes in women conceiving during treatment with an LHRH agonist. Hum. Reprod. 7, 409-412.
16. Jackson, A.E., Curtis, P., Amso, N. and Shaw, R.W. (1992) Exposure to LHRH agonists in early pregnancy following the commencement of mid-luteal buserelin for IVF stimulation. Hum. Reprod., 7, 1222-1224.
17. Lanzone, A., Panetta, V., DiSimone, N. et al. (1989) Effect of gonadotrophin releasing-hormone and related analogue on human luteal cell function in vitro. Hum. Reprod., 4, 906-909.
18. Lejeune, B., Barlow, P., Puissant, F. et al. (1990) Use of buserelin acetate in an in vitro fertilisation program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatment. Fertil. Steril., 54, 475-481.
19. Lockwood, G.M., Robinson, J.N. and Barlow, D.H. (1992) Pregnancy outcome following inadvertent luteal phase initiation of gonadotrophin-releasing hormone agonist (GnRH-a) treatment in superovulation cycles. J. Reprod. Fertil., 10, 54 (Abstract A03).
20. Martinez, F., Barri, P.N. and Coroleu, V. (1988) Case report: accidental GnRH agonist administration during early pregnancy. Hum. Reprod., 3, p. 669.
21. Serafini, P., Batzofin, J., Kerin, J. and Marrs, R.P. (1988) Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation. Fertil. Steril., 50, 371-372.
22. Skarin, G., Bergquist, C., Nillius, S.J. and Wide, L. (1981) LRH agonist effects on luteal function and early human pregnancy. Acta Endocrinol., 97, S87.
23. Smitz, J., Camus, M., Devroey, P. et al. (1991) The influence of inadvertent intranasal buserelin administration in early pregnancy. Hum. Reprod., 6, 290-293.
24. Sopelak, V.M. and Hodgen, G.D. (1987) Infusion of gonadotrophin-releasing hormone agonist during pregnancy: maternal and fetal responses in primates. Am. J. Obstet. Gynecol., 157, 755.
25. Valbuena, D. and Simon, C. (1997) Effect of disruption versus continuation of gonadotrophin releasing hormone agonist after human chorionic hormone administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization. Hum. Reprod., 10, 2118-2122.
26. Weissmann, A. and Shoham, A. (1993) Favourable pregnancy outcome after administration of long-acting gonadotrophin-releasing hormone agonist in the mid-luteal phase. Hum. Reprod., 8, 496-497.
27. Young, D.C., Snabes, M.C. and Poindexter, A.N. (1993) GnRH agonist exposure during the first trimester of pregnancy. Obstet. Gynecol., 4, 587-588.